nach oben

Irish Journal of Medical Science (1971 -)

Erschienen in:

01.02.2016 | Original Article

Systematic analysis to identify a key role of CDK1 in mediating gene interaction networks in cervical cancer development

verfasst von: Y. Luo, Y. Wu, Y. Peng, X. Liu, J. Bie, S. Li

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study aims to identify corresponding differentially expressed genes in cervical cancer by comparing gene expression profiles between normal and cervical cancer samples.

Method

To identify differentially expressed genes in cervical cancer, two groups of Affymetrix microarray data available online were analyzed. One group consisted of 43 carcinomatous cervical epithelial cell samples, and the other was composed of 17 healthy cervical epithelial cell samples, both from the Amerindian. R packages—GO.db, KEGG.db and KEGGREST were used to detect GO categories and KEGG pathways with significant overrepresentation in differentially expressed genes comparing with the whole genome. Cytoscape was utilized to construct biological networks.

Results

By comparing gene expression profile of normal and cervical cancer samples, 122 differentially expressed genes were identified including 46 up-regulated genes and 76 down-regulated genes. Using the identified differentially expressed genes, a large and a small biological network was constructed. In addition, 402 GO biological processes and 9 KEGG pathways were over-represented. Top significant biological processes included cell cycle and cell proliferation. Moreover, top significant KEGG pathways were oocyte meiosis, cell cycle and progesterone-mediated oocyte maturation. Most importantly, CDK1 frequently appeared in these processes and pathways, which indicated its significant role in the progression of cervical cancer.

Conclusion

CDK1 plays a comprehensive role in mediating genetic networks implicated in the progression of cervical cancer. Novel therapeutics targeting CDK1 or its related pathways might help improve prognosis of advanced stage cervical cancer.

Nur mit Berechtigung zugänglich

Petignat P, Roy M (2007) Diagnosis and management of cervical cancer. BMJ 335(7623):765–768PubMedPubMedCentralCrossRef

Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10(8):789–799PubMedCrossRef

Thomas A et al (2013) Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease. Cancer Med 2(6):836–848PubMedPubMedCentralCrossRef

Cheng Q et al (2002) Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma. Int J Cancer 98(3):419–426PubMedCrossRef

Wong YF et al (2006) Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer 118(10):2461–2469PubMedCrossRef

Guardado-Estrada M et al (2012) The Amerindian mtDNA haplogroup B2 enhances the risk of HPV for cervical cancer: de-regulation of mitochondrial genes may be involved. J Hum Genet 57(4):269–276PubMedCrossRef

Carvalho BS, Irizarry RA (2010) A framework for oligonucleotide microarray preprocessing. Bioinformatics 26(19):2363–2367PubMedPubMedCentralCrossRef

Tavazoie S et al (1999) Systematic determination of genetic network architecture. Nat Genet 22(3):281–285PubMedCrossRef

Keshava Prasad TS et al (2009) Human protein reference database–2009 update. Nucleic Acids Res 37(Database issue):D767–D772

10.

Chatr-Aryamontri A et al (2013) The BioGRID interaction database: 2013 update. Nucleic Acids Res 41(Database issue):D816–D823

11.

McDowall MD, Scott MS, Barton GJ (2009) PIPs: human protein-protein interaction prediction database. Nucleic Acids Res 37(Database issue):D651–D656

12.

Smoot ME et al (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27(3):431–432PubMedPubMedCentralCrossRef

13.

Santin AD et al (2005) Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology 331(2):269–291PubMedCrossRef

14.

Rajkumar T et al (2011) Identification and validation of genes involved in cervical tumourigenesis. BMC Cancer 11:80PubMedPubMedCentralCrossRef

15.

Seo MJ et al (2005) New approaches to pathogenic gene function discovery with human squamous cell cervical carcinoma by gene ontology. Gynecol Oncol 96(3):621–629PubMedCrossRef

16.

Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25(1):9–34PubMedCrossRef

17.

Zhai Y et al (2005) Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Res 65(15):6543–6550PubMedCrossRef

18.

Sheu BC et al (2003) Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Cancer Res 63(19):6537–6542PubMed

19.

Song JY et al (2008) Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer. Int J Gynecol Cancer 18(5):1051–1059PubMedCrossRef

20.

Cho H et al (2008) Clinical significance of osteopontin expression in cervical cancer. J Cancer Res Clin Oncol 134(8):909–917PubMedCrossRef

21.

Conesa-Zamora P (2013) Role of cell cycle biomarkers in human papillomavirus related uterine lesions. Curr Pharm Des 19(8):1412–1424PubMed

22.

Lau E et al (2007) The role of pre-replicative complex (pre-RC) components in oncogenesis. FASEB J 21(14):3786–3794PubMedCrossRef

23.

Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16(1):1–17PubMedPubMedCentralCrossRef

24.

Yun J et al (1999) p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor. J Biol Chem 274(42):29677–29682PubMedCrossRef

25.

Cho NH et al (2006) Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection. Cancer Lett 232(2):170–178PubMedCrossRef

26.

Cerciello F et al (2005) G2/M cell cycle checkpoint is functional in cervical cancer patients after initiation of external beam radiotherapy. Int J Radiat Oncol Biol Phys 62(5):1390–1398PubMedCrossRef

27.

Malumbres M, Barbacid M (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30(11):630–641PubMedCrossRef

28.

Hall M, Peters G (1996) Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 68:67–108PubMedCrossRef

29.

Shapiro GI (2006) Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 24(11):1770–1783PubMedCrossRef

30.

Zeng Q et al (2012) IPP5, a novel inhibitor of protein phosphatase 1, suppresses tumor growth and progression of cervical carcinoma cells by inducing G2/M arrest. Cancer Genet 205(9):442–452PubMedCrossRef

31.

Emanuel S et al (2005) The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases. Cancer Res 65(19):9038–9046PubMedCrossRef

32.

Sutherland RL, Musgrove EA (2009) CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER + disease. Breast Cancer Res 11(6):112PubMedPubMedCentralCrossRef

33.

Gao SY et al (2014) Downregulation of Cdk1 and CyclinB1 Expression Contributes to Oridonin-induced Cell Cycle Arrest at G2/M Phase and Growth Inhibition in SGC-7901 Gastric Cancer Cells. Asian Pac J Cancer Prev 15(15):6437–6441PubMedCrossRef

Titel: Systematic analysis to identify a key role of CDK1 in mediating gene interaction networks in cervical cancer development
verfasst von: Y. Luo
Y. Wu
Y. Peng
X. Liu
J. Bie
S. Li
Publikationsdatum: 01.02.2016
Verlag: Springer London
Erschienen in: Irish Journal of Medical Science (1971 -) / Ausgabe 1/2016
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI: https://doi.org/10.1007/s11845-015-1283-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Systematic analysis to identify a key role of CDK1 in mediating gene interaction networks in cervical cancer development

Abstract

Objective

Method

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Objective

Method

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2016

Clinical significance of lesser occipital nerve preservation during micro-vascular decompression for hemi-facial spasm

2014 Conway review lecture, Royal Academy of Medicine in Ireland: “S6, drugs and RCK and Bowl”

Auditory canal exostoses in Irish surfers

Comments on the paper “Medicolegal implications of accuracy of GP referral letters to specialist breast clinic”

Assessment of hospital inpatient discharge summaries, written for general practitioners, from a department of medicine for the elderly service in a large teaching hospital

The evaluation of brain natriuretic peptide changes and difficult airway predictors during perioperative period of pregnancy

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin